MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX.

Oncol Lett · 2017 · PMC5494676 · PMID 28693229

Europe PMC DOI

hedged sentence

0.4430

closest p · 8.9× alpha

0.4430

boldest claim

The sentences

did not reach statistical significanceP=0.4430not close (p > 0.1)

The association with RECIST response of the remaining 3 miRNAs included in the validation phase did not reach statistical significance: miR-877-5p (P=0.4430), miR-642a-3p (P=0.1974) and miR-642b-3p (P=0.3688).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.